Safety and Tolerability Study of AutoSynVax™ Vaccine in Subjects With Advanced Cancer
Clinical trial NCT02992977 · TERMINATED
Trial details
- NCT number
- NCT02992977
- Sponsor
- Agenus Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2018-12-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.